David W Cescon (David Cescon, D W Cescon, Dave W Cescon)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 41

Top Topics

Endoplasmic Reticulum

Estrogen Receptor

Top Venues

Nature communications

NPJ breast cancer

JCO precision oncology

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Christopher Zhang, Benson Z Wu, Caterina Di Ciano-Oliveira, Yin Fang Wu, Sharon S Khavkine Binstock, Isabel Soria-Bretones, Nhu-An Pham, Andrew J Elia, Raj Chari, Wan L Lam, Mark R Bray, Tak W Mak, Ming Sound Tsao, David W Cescon, Kelsie L Thu
Identification of KIFC1 as a putative vulnerability in lung cancers with centrosome amplification. Cancer gene therapy (2024)
Aditya Bardia, Komal L Jhaveri, Seock-Ah Im, Sonia Pernas, Michelino De Laurentiis, Shu-Sen Wang, Noelia Martínez Jañez, Giuliano Borges, David W Cescon, Masaya Hattori, Yen-Shen Lu, Erika Paige Hamilton, Qingyuan Zhang, Junji Tsurutani, Kevin M Kalinsky, Pedro Emanuel Rubini Liedke, Lu Xu, Rick M Fairhurst, Sabrina Khan, Neelima Denduluri, Hope S Rugo, Binghe Xu, Barbara Pistilli, null null
Datopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: Primary Results From TROPION-Breast01. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Chang-Ching Lin, Tsung-Cheng Chang, Yunguan Wang, Lei Guo, Yunpeng Gao, Emmanuel Bikorimana, Andrew Lemoff, Yisheng V Fang, He Zhang, Yanfeng Zhang, Dan Ye, Isabel Soria-Bretones, Alberto Servetto, Kyung-Min Lee, Xuemei Luo, Joseph J Otto, Hiroaki Akamatsu, Fabiana Napolitano, Ram S Mani, David W Cescon, Lin Xu, Yang Xie, Joshua T Mendell, Ariella B Hanker, Carlos L Arteaga
PRMT5 is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer. Nature communications 15 (1) (2024)
Chang-Ching Lin, Tsung-Cheng Chang, Yunguan Wang, Lei Guo, Yunpeng Gao, Emmanuel Bikorimana, Andrew Lemoff, Yisheng V Fang, He Zhang, Yanfeng Zhang, Dan Ye, Isabel Soria-Bretones, Alberto Servetto, Kyung-Min Lee, Xuemei Luo, Joseph J Otto, Hiroaki Akamatsu, Fabiana Napolitano, Ram S Mani, David W Cescon, Lin Xu, Yang Xie, Joshua T Mendell, Ariella B Hanker, Carlos L Arteaga
PRMT5 is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer. Nature communications 15 (1) (2024)
Seock-Ah Im, Javier Cortes, David W Cescon, Mastura Md Yusof, Hiroji Iwata, Norikazu Masuda, Toshimi Takano, Chiun-Sheng Huang, Chi-Feng Chung, Koichiro Tsugawa, Yeon Hee Park, Koji Matsumoto, Kenichi Inoue, Ava Kwong, Sherene Loi, Wei Fu, Wilbur Pan, Vassiliki Karantza, Hope S Rugo, Peter Schmid
Results from the randomized KEYNOTE-355 study of pembrolizumab plus chemotherapy for Asian patients with advanced TNBC. NPJ breast cancer 10 (1) (2024)
Chang-Ching Lin, Tsung-Cheng Chang, Yunguan Wang, Lei Guo, Yunpeng Gao, Emmanuel Bikorimana, Andrew Lemoff, Yisheng V Fang, He Zhang, Yanfeng Zhang, Dan Ye, Isabel Soria-Bretones, Alberto Servetto, Kyung-Min Lee, Xuemei Luo, Joseph J Otto, Hiroaki Akamatsu, Fabiana Napolitano, Ram S Mani, David W Cescon, Lin Xu, Yang Xie, Joshua T Mendell, Ariella B Hanker, Carlos L Arteaga
PRMT5 is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer. Nature communications 15 (1) (2024)
Suzanne Kazandjian, Emmanuelle Rousselle, Matthew Dankner, David W Cescon, Anna Spreafico, Kim Ma, Petr Kavan, Gerald Batist, April A N Rose
The Clinical, Genomic, and Transcriptomic Landscape of BRAF Mutant Cancers. Cancers 16 (2) (2024)
Suzanne Kazandjian, Emmanuelle Rousselle, Matthew Dankner, David W Cescon, Anna Spreafico, Kim Ma, Petr Kavan, Gerald Batist, April A N Rose
The Clinical, Genomic, and Transcriptomic Landscape of BRAF Mutant Cancers. Cancers 16 (2) (2024)
Chang-Ching Lin, Tsung-Cheng Chang, Yunguan Wang, Lei Guo, Yunpeng Gao, Emmanuel Bikorimana, Andrew Lemoff, Yisheng V Fang, He Zhang, Yanfeng Zhang, Dan Ye, Isabel Soria-Bretones, Alberto Servetto, Kyung-Min Lee, Xuemei Luo, Joseph J Otto, Hiroaki Akamatsu, Fabiana Napolitano, Ram S Mani, David W Cescon, Lin Xu, Yang Xie, Joshua T Mendell, Ariella B Hanker, Carlos L Arteaga
PRMT5 is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer. Nature communications 15 (1) (2024)
Kai V Slaughter, Eric N Donders, Michael S Jones, Sami G Sabbah, Mitchell J Elliott, Brian K Shoichet, David W Cescon, Molly S Shoichet
Ionizable Drugs Enable Intracellular Delivery of Co-Formulated siRNA. Advanced materials (Deerfield Beach, Fla.) (2024)
Chang-Ching Lin, Tsung-Cheng Chang, Yunguan Wang, Lei Guo, Yunpeng Gao, Emmanuel Bikorimana, Andrew Lemoff, Yisheng V Fang, He Zhang, Yanfeng Zhang, Dan Ye, Isabel Soria-Bretones, Alberto Servetto, Kyung-Min Lee, Xuemei Luo, Joseph J Otto, Hiroaki Akamatsu, Fabiana Napolitano, Ram S Mani, David W Cescon, Lin Xu, Yang Xie, Joshua T Mendell, Ariella B Hanker, Carlos L Arteaga
PRMT5 is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer. Nature communications 15 (1) (2024)
Sathyen A Prabhu, Omar Moussa, Christophe Gonçalves, Judith H LaPierre, Hsiang Chou, Fan Huang, Vincent R Richard, Pault Y M Ferruzo, Elizabeth M Guettler, Isabel Soria-Bretones, Laura Kirby, Natascha Gagnon, Jie Su, Jennifer Silvester, Sai Sakktee Krisna, April A N Rose, Karen E Sheppard, David W Cescon, Frédérick A Mallette, René Peiman Zahedi, Christoph H Borchers, Sonia V Del Rincón, Wilson H Miller
Inhibition of the MNK1/2-eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer. Molecular cancer therapeutics 22 (2) (2023)
David W Cescon, John Hilton, Serafin Morales Murillo, Rachel M Layman, Timothy J Pluard, Belinda Yeo, In Hae Park, Louise Provencher, Sung-Bae Kim, Young-Hyuck Im, Anastasia Wyce, Anu Shilpa Krishnatry, Kirsty Hicks, Qu Zhang, Olena Barbash, Ahmed Khaled, Thierry Horner, Arindam Dhar, Mafalda Oliveira, Joseph A Sparano
A Phase I/II Study of GSK525762 Combined With Fulvestrant in Patients With Hormone Receptor-Positive/HER2-Negative (HR+/HER2-) Advanced or Metastatic Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Sherene Loi, Roberto Salgado, Thomas Powles, Javier Cortes, David W Cescon, Eric P Winer, Deborah L Toppmeyer, Hope S Rugo, Michelino De Laurentiis, Rita Nanda, Hiroji Iwata, Ahmad Awada, Antoinette R Tan, Yuan Sun, Vassiliki Karantza, Anran Wang, Lingkang Huang, Assieh Saadatpour, Razvan Cristescu, Jennifer Yearley, Jared Lunceford, Petar Jelinic, Sylvia Adams
Association Between Biomarkers and Clinical Outcomes of Pembrolizumab Monotherapy in Patients With Metastatic Triple-Negative Breast Cancer: KEYNOTE-086 Exploratory Analysis. JCO precision oncology 7 (2023)
Sathyen A Prabhu, Omar Moussa, Christophe Gonçalves, Judith H LaPierre, Hsiang Chou, Fan Huang, Vincent R Richard, Pault Y M Ferruzo, Elizabeth M Guettler, Isabel Soria-Bretones, Laura Kirby, Natascha Gagnon, Jie Su, Jennifer Silvester, Sai Sakktee Krisna, April A N Rose, Karen E Sheppard, David W Cescon, Frédérick A Mallette, René Peiman Zahedi, Christoph H Borchers, Sonia V Del Rincón, Wilson H Miller
Inhibition of the MNK1/2-eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer. Molecular cancer therapeutics 22 (2) (2023)
Sherene Loi, Roberto Salgado, Thomas Powles, Javier Cortes, David W Cescon, Eric P Winer, Deborah L Toppmeyer, Hope S Rugo, Michelino De Laurentiis, Rita Nanda, Hiroji Iwata, Ahmad Awada, Antoinette R Tan, Yuan Sun, Vassiliki Karantza, Anran Wang, Lingkang Huang, Assieh Saadatpour, Razvan Cristescu, Jennifer Yearley, Jared Lunceford, Petar Jelinic, Sylvia Adams
Association Between Biomarkers and Clinical Outcomes of Pembrolizumab Monotherapy in Patients With Metastatic Triple-Negative Breast Cancer: KEYNOTE-086 Exploratory Analysis. JCO precision oncology 7 (2023)
Peter Lin, Corey Lourenco, Jennifer Cruickshank, Luis Palomero, Jenna E van Leeuwen, Amy H Y Tong, Katherine Chan, Samah El Ghamrasni, Miguel Angel Pujana, David W Cescon, Jason Moffat, Linda Z Penn
Topoisomerase 1 Inhibition in MYC-Driven Cancer Promotes Aberrant R-Loop Accumulation to Induce Synthetic Lethality. Cancer research (2023)
David W Cescon, Peter Schmid, Hope S Rugo, Seock-Ah Im, Mastura Md Yusof, Carlos Gallardo, Oleg Lipatov, Carlos H Barrios, Jose Perez-Garcia, Hiroji Iwata, Norikazu Masuda, Marco Torregroza Otero, Erhan Gokmen, Sherene Loi, Amin Haiderali, Xuan Zhou, Zifang Guo, Allison Martin Nguyen, Javier Cortes
Health-Related Quality of Life With Pembrolizumab+Chemotherapy Versus Placebo+Chemotherapy for Advanced Triple-Negative Breast Cancer: KEYNOTE-355. Journal of the National Cancer Institute (2023)
Chang-Ching Lin, Tsung-Cheng Chang, Yunguan Wang, Lei Guo, Yunpeng Gao, Emmanuel Bikorimana, Andrew Lemoff, Yisheng Fang, He Zhang, Yanfeng Zhang, Dan Ye, Isabel Soria-Bretones, Alberto Servetto, Kyung-Min Lee, Xuemei Luo, Joseph Otto, Hiroaki Akamatsu, Fabiana Napolitano, Ram S Mani, David W Cescon, Lin Xu, Yang Xie, Joshua T Mendell, Ariella B Hanker, Carlos L Arteaga
Protein arginine methyltransferase 5 (PRMT5) is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer. Research square (2023)
Sathyen A Prabhu, Omar Moussa, Christophe Gonçalves, Judith H LaPierre, Hsiang Chou, Fan Huang, Vincent R Richard, Pault Y M Ferruzo, Elizabeth M Guettler, Isabel Soria-Bretones, Laura Kirby, Natascha Gagnon, Jie Su, Jennifer Silvester, Sai Sakktee Krisna, April A N Rose, Karen E Sheppard, David W Cescon, Frédérick A Mallette, René Peiman Zahedi, Christoph H Borchers, Sonia V Del Rincón, Wilson H Miller
Inhibition of the MNK1/2-eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer. Molecular cancer therapeutics 22 (2) (2023)
Isabel Soria-Bretones, Kelsie L Thu, Jennifer Silvester, Jennifer Cruickshank, Samah El Ghamrasni, Wail Ba-Alawi, Graham C Fletcher, Reza Kiarash, Mitchell J Elliott, Jordan J Chalmers, Andrea C Elia, Albert Cheng, April A N Rose, Mark R Bray, Benjamin Haibe-Kains, Tak Wah Mak, David W Cescon
The spindle assembly checkpoint is a therapeutic vulnerability of CDK4/6 inhibitor-resistant ER + breast cancer with mitotic aberrations. Science advances 8 (36) (2022)
David W Cescon, Kevin Kalinsky, Angela M DeMichele
Can a Late Interception by Circulating Tumor DNA Deliver a Win in Estrogen Receptor-Positive Early Breast Cancer? Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (22) (2022)
Ellen Langille, Khalid N Al-Zahrani, Zhibo Ma, Minggao Liang, Liis Uusküla-Reimand, Roderic Espin Garcia, Katie Teng, Ahmad A Malik, Helga Bergholtz, Samah El Ghamrasni, Somaieh Afiuni-Zadeh, Ricky Tsai, Sana Alvi, Andrew J Elia, YiQing Lü, Robin Hyunseo Oh, Katelyn J Kozma, Daniel Trcka, Masahiro Narimatsu, Jeff C Liu, Thomas Nguyen, Seda Avcioglu Barutcu, Sampath Kumar Loganathan, Rod Bremner, Gary D Baider, Sean E Egan, David W Cescon, Therese Sørlie, Jeffrey L Wrana, Hartland Warren Jackson, Michael D Wilson, Agnieszka K Witkiewicz, Erik S Knudsen, Miguel Angel Pujana, Geoffrey M Wahl, Daniel Schramek
Loss of Epigenetic Regulation Disrupts Lineage Integrity, Induces Aberrant Alveogenesis, and Promotes Breast Cancer. Cancer discovery 12 (12) (2022)
Jenna E van Leeuwen, Wail Ba-Alawi, Emily Branchard, Jennifer Cruickshank, Wiebke Schormann, Joseph Longo, Jennifer Silvester, Peter L Gross, David William Andrews, David W Cescon, Benjamin Haibe-Kains, Linda Z Penn, Deena M A Gendoo
Computational pharmacogenomic screen identifies drugs that potentiate the anti-breast cancer activity of statins. Nature communications 13 (1) (2022)
Elisabeth Prince, Jennifer Cruickshank, Wail Ba-Alawi, Kelsey Hodgson, Jillian Haight, Chantal Tobin, Andrew Wakeman, Alona Avoulov, Valentina Topolskaia, Mitchell J Elliott, Alison P McGuigan, Hal K Berman, Benjamin Haibe-Kains, David W Cescon, Eugenia Kumacheva
Biomimetic hydrogel supports initiation and growth of patient-derived breast tumor organoids. Nature communications 13 (1) (2022)
John Hilton, Karen Gelmon, Philippe L Bedard, Dongsheng Tu, Hong Xu, Anna V Tinker, Rachel Goodwin, Scott A Laurie, Derek Jonker, Aaron R Hansen, Zachary W Veitch, Daniel J Renouf, Linda Hagerman, Hongbo Lui, Bingshu E Chen, Deb Kellar, Irene Li, Sung-Eun Lee, Takako Kono, Brian Yu Chieh Cheng, Damian Yap, Daniel Lai, Sean Beatty, John Soong, Kathleen I Pritchard, Isabel Soria-Bretones, Eric Chen, Harriet Feilotter, Moira Rushton, Lesley Seymour, Samuel A J R Aparicio, David W Cescon
Results of the phase I CCTG IND.231 trial of CX-5461 in patients with advanced solid tumors enriched for DNA-repair deficiencies. Nature communications 13 (1) (2022)
Razvan Cristescu, Michael Nebozhyn, Chunsheng Zhang, Andrew Albright, Julie Kobie, Lingkang Huang, Qing Zhao, Anran Wang, Hua Ma, Z Alexander Cao, Michael Morrissey, Antoni Ribas, Petros D Grivas, David W Cescon, Terrill K McClanahan, Alexandra Snyder, Mark Ayers, Jared Lunceford, Andrey Loboda
Transcriptomic Determinants of Response to Pembrolizumab Monotherapy across Solid Tumor Types. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (8) (2022)
Matthew Dankner, Yifan Wang, Rouhi Fazelzad, Benny Johnson, Caroline A Nebhan, Ibiayi Dagogo-Jack, Nathaniel J Myall, Georg Richtig, Jillian Wilhelmina Paulina Bracht, Marco Gerlinger, Eiji Shinozaki, Takayuki Yoshino, Daisuke Kotani, Jason R Fangusaro, Oliver Gautschi, Julien Mazieres, Jeffrey A Sosman, Edmund S Kopetz, Vivek Subbiah, Michael A Davies, Anna L Groover, Ryan J Sullivan, Keith T Flaherty, Douglas B Johnson, Andrea Benedetti, David W Cescon, Anna Spreafico, George Zogopoulos, April A N Rose
Clinical Activity of Mitogen-Activated Protein Kinase-Targeted Therapies in Patients With Non-V600 BRAF-Mutant Tumors. JCO precision oncology 6 (2022)
Samah El Ghamrasni, Rene Quevedo, James R Hawley, Parisa Mazrooei, Youstina Hanna, Iulia Cirlan, Helen Zhu, Jeffrey P Bruce, Leslie E Oldfield, S Y Cindy Yang, Paul Guilhamon, Jüri Reimand, David W Cescon, Susan J Done, Mathieu Lupien, Trevor J Pugh
Mutations in Noncoding Cis-Regulatory Elements Reveal Cancer Driver Cistromes in Luminal Breast Cancer. Molecular cancer research : MCR (2021)
Brooke E Wilson, Chiara Gorrini, David W Cescon
Breast cancer immune microenvironment: from pre-clinical models to clinical therapies. Breast cancer research and treatment (2021)
Zachary W Veitch, Domen Ribnikar, Derek Tilley, Patricia A Tang, Karen King, Philippe L Bedard, Sasha Lupichuk, David W Cescon
No evidence of disease versus residual disease in long-term responders to first-line HER2-targeted therapy for metastatic breast cancer. British journal of cancer 126 (6) (2021)
Janosch Ortmann, Ladislav Rampášek, Elijah Tai, Arvind Singh Mer, Ruoshi Shi, Erin L Stewart, Celine Mascaux, Aline Fares, Nhu-An Pham, Gangesh Beri, Christopher Eeles, Denis Tkachuk, Chantal Ho, Shingo Sakashita, Jessica Weiss, Xiaoqian Jiang, Geoffrey Liu, David W Cescon, Catherine A O'Brien, Sheng Guo, Ming Sound Tsao, Benjamin Haibe-Kains, Anna Goldenberg
Assessing therapy response in patient-derived xenografts. Science translational medicine 13 (620) (2021)
Rosemary Yu, Joseph Longo, Jenna E van Leeuwen, Cunjie Zhang, Emily Branchard, Mohamad Elbaz, David W Cescon, Richard R Drake, James W Dennis, Linda Z Penn
Mevalonate Pathway Inhibition Slows Breast Cancer Metastasis via Reduced N-glycosylation Abundance and Branching. Cancer research 81 (10) (2021)
Qin Wu, Wail Ba-Alawi, Genevieve Deblois, Jennifer Cruickshank, Shili Duan, Evelyne Lima-Fernandes, Jillian Haight, Seyed Ali Madani Tonekaboni, Anne-Marie N Fortier, Hellen Kuasne, Trevor D McKee, Hassan Mahmoud, Michelle Kushida, Sarina Cameron, Nergiz Dogan-Artun, WenJun Chen, Yan Nie, Lan Xin Zhang, Ravi N Vellanki, Stanley Zhou, Panagiotis Prinos, Bradly G Wouters, Peter B Dirks, Susan J Done, Morag Park, David W Cescon, Benjamin Haibe-Kains, Mathieu Lupien, Cheryl H Arrowsmith
GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer. Nature communications 11 (1) (2020)
David W Cescon, Scott V Bratman, Steven M Chan, Lillian L Siu
Circulating tumor DNA and liquid biopsy in oncology. Nature cancer 1 (3) (2020)
Mitchell J Elliott, Marguerite Ennis, Kathleen I Pritchard, Carol Townsley, Dave Warr, Christine Elser, Eitan Amir, Philippe L Bedard, Lakshmi Rao, Vuk Stambolic, Srikala S Sridhar, Pamela J Goodwin, David W Cescon
Association between BMI, vitamin D, and estrogen levels in postmenopausal women using adjuvant letrozole: a prospective study. NPJ breast cancer 6 (2020)
Ryan J O Dowling, Joseph A Sparano, Pamela J Goodwin, Francois-Clement Bidard, David W Cescon, Sarat Chandarlapaty, Joseph O Deasy, Mitch Dowsett, Robert C Gray, Norah L Henry, Funda Meric-Bernstam, Jane Perlmutter, George W Sledge, Mangesh A Thorat, Scott V Bratman, Lisa Anne Carey, Martin C Chang, Angela DeMichele, Marguerite Ennis, Katarzyna J Jerzak, Larissa A Korde, Ana Elisa Lohmann, Eleftherios P Mamounas, Wendy R Parulekar, Meredith M Regan, Daniel Schramek, Vuk Stambolic, Timothy J Whelan, Antonio C Wolff, James R Woodgett, Kevin Kalinsky, Daniel F Hayes
Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 2: Approaches to Predict and Identify Late Recurrence, Research Directions. JNCI cancer spectrum 3 (4) (2019)
David B Page, Harry Bear, Sangeetha Prabhakaran, Margaret E Gatti-Mays, Alexandra Thomas, Erin Cobain, Heather McArthur, Justin M Balko, Sofia R Gameiro, Rita Nanda, James L Gulley, Kevin Kalinsky, Julia White, Jennifer Litton, Steven J Chmura, Mei-Yin Polley, Benjamin Vincent, David W Cescon, Mary L Disis, Joseph A Sparano, Elizabeth A Mittendorf, Sylvia Adams
Two may be better than one: PD-1/PD-L1 blockade combination approaches in metastatic breast cancer. NPJ breast cancer 5 (2019)
Ryan J O Dowling, Kevin Kalinsky, Daniel F Hayes, Francois-Clement Bidard, David W Cescon, Sarat Chandarlapaty, Joseph O Deasy, Mitch Dowsett, Robert C Gray, Norah L Henry, Funda Meric-Bernstam, Jane Perlmutter, George W Sledge, Scott V Bratman, Lisa Anne Carey, Martin C Chang, Angela DeMichele, Marguerite Ennis, Katarzyna J Jerzak, Larissa A Korde, Ana Elisa Lohmann, Eleftherios P Mamounas, Wendy R Parulekar, Meredith M Regan, Daniel Schramek, Vuk Stambolic, Mangesh A Thorat, Timothy J Whelan, Antonio C Wolff, James R Woodgett, Joseph A Sparano, Pamela J Goodwin
Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 1: Late Recurrence: Current Understanding, Clinical Considerations. JNCI cancer spectrum 3 (4) (2019)
Margaret E Gatti-Mays, Justin M Balko, Sofia R Gameiro, Harry D Bear, Sangeetha Prabhakaran, Jami Fukui, Mary L Disis, Rita Nanda, James L Gulley, Kevin Kalinsky, Houssein Abdul Sater, Joseph A Sparano, David W Cescon, David B Page, Heather McArthur, Sylvia Adams, Elizabeth A Mittendorf
If we build it they will come: targeting the immune response to breast cancer. NPJ breast cancer 5 (2019)
K L Thu, I Soria-Bretones, T W Mak, David W Cescon
Targeting the cell cycle in breast cancer: towards the next phase. Cell cycle (Georgetown, Tex.) 17 (15) (2018)